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Abstract 
  BACKGROUND:  Evidences  support  the  possible  involvement  of  microorganisms  such  as 
Chlamydia  pneumonia  in  the  pathogenesis  of  ischemic  heart  diseases  through  a  chronic 
inflammatory process. The aim of this study was to determine the relation between Chlamydia 
pneumoniae seropositivity with acute myocardial infarction and its related risk factors. 
  METHODS: In this case-control study, 88 patients admitted in CCU with a diagnosis of acute 
coronary syndrome, without a history of chronic diseases including cancers were selected as 
cases and 49 surgical patients without an evidence of cardiovascular disease according to clinical 
examinations and ECG were selected as controls. Demographic characteristics and background 
risk factors were obtained using a questionnaire by expert nurses. Venous blood sample was 
obtained from participants for measuring the anti Chlamydia IgG and  IgM antibodies using 
ELISA method. The prevalence of antibodies was compared in both groups and its relation with 
coronary syndrome was evaluated. 
  RESULTS: 88 and 49 patients were enrolled in case and control groups, respectively. Mean age 
of patients and the controls was 14 ± 59.7 and 13 ± 56.9 years, respectively (P = 0.26). Anti 
Chlamydia  IgG  seropositivity  rate  was  63(71.9%)  and  23(46.9%)  in  case  and  controlcontrol 
groups, respectively (P < 0.01; OR: 2.85; CI 95%: 1.38 - 5.9). Anti Chlamydia IgM was positive in 
1 patient and 1 control. Anti Chlamydia IgG seropositivity rate was higher in patients older than 
50 years old than those younger than 50 years old (OR: 2.83; CI 95%: 1.31 -1.14). There was a 
significant relation between BMI, smoking and Anti Chlamydia IgG seropositivity. 
  CONCLUSION: Considering the relation between anti Chlamydia antibody IgG seropositivity 
with BMI and myocardial infarction, it seems that appropriate diagnosis and treatment of these 
prone patients can be benefical. 
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Introduction 
Atherosclerosis  considered  as  the  most  important 
causes of mortality and morbidity worldwide. Various 
factors  have  been  introduced  in  the  pathology  of 
atherosclerosis and acute myocardial infarction such 
as:  defect  in  lipid  metabolism,  change  in  the 
concentration of various lipoproteins of cholesterol, 
genetic factors, diabetes, age, sex, and smoking habit. 
These factors are known to be involved directly or 
indirectly in atherosclerotic changes of arteries.1  
  Today,  in  addition  to  previously  identified 
traditional risk factors, other factors are reported to 
play a role in atherosclerosis.2 
  Of  these  factors  microorganisms  such  as 
Chlamydia  pneumoniae,  Cytomegalovirus, 
Helicobacter  pylori,  Streptococcus  sanguis  and 
Herpes type 1 and 2 can be noted. Microorganisms 
can invade the endothelium directly or indirectly and 
for  example  can  cause  endothelial  damage  by 
releasing endotoxins and lipopolysaccharides into the 
blood.  On  the  other  hand  systemic  responses  to 
infections such as cytokine release can cause changes 
in lipid profile and make the endothelium prone to 
thrombosis and lead to formation of atherosclerotic 
plaque or thrombus.3,4  
  Of these infections, infections such as Chlamydia 
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pneumoniae  which  there  is  an  effective  antibiotic 
treatment  for  them  are  very  important.  Infections 
caused  by  Chlamydia  pneumonia  are  considered  to 
participate  in  inflammatory  processes  leading  to 
coronary  artery  disease.  After  primary  infection;  the 
bacteria  remain  dormant  intracellulary  causing  a 
chronic  inflammatory  stimulus.5  Recent 
seroepidemiologic  findings  in  patients  defected  by 
coronary artery diseases have shown a relation between 
Chlamydia pneumoniae and atherosclerosis.6 
  In some studies a significant positive association 
was  found  between  being  overweight  and  IgG 
antibodies for Chlamydia pneumoniae.7 
  For the first time in thereigon, this study aimed to 
investigate  the  role  of  Chlamydia  pneumoniae 
seropositivity with acute myocardial infarction and its 
related risk factors. 
Materials and Methods 
In this case   control study, 88 patients admitted in 
CCU  with  a  diagnosis  of acute  coronary  syndrome 
without  a  history  of  chronic  diseases  including 
cancers were selected as case group and 49 surgical 
patients (ENT patients, gynecology, hernia) without 
an  evidence  of  cardiovascular  disease  according  to 
clinical  examinations  and  ECG  were  selected  as 
control group. 
  Demographic characteristics and background risk 
factors were obtained using a questionnaire by expert 
nurses.  Venous  blood  sample  (5  cc)  was  obtained 
from  all  participants  of  two  studied  groups  for 
measuring  the  anti  Chlamydia  IgG  and  IgM 
antibodies using ELISA method by MEDEC KIT. 
  Anti  Chlamydia  pneumoniae  seropositivity  rate 
was  compared  in  case  and  control  groups  and  its 
relation with coronary syndrome was evaluated. 
  Obtained data from case and control groups was 
analyzed by SPSS software and forward conditional 
logistic regression and chi square statistical tests. 
Results 
In this study 88 and 49 patients were enrolled in case 
and control groups, respectively.Mean age of patients 
in  case  and  control  groups  was  14  ±  59.7  and  
13  ±  56.9  years,  respectively  (P  =  0.26).  Other 
demographic  characteristics  and  risk  factors  are 
presented in Table 1. 
  Anti  Chlamydia  IgG  seropositivity  rate  was 
63(71.9%) and 23(46.9%) in case and control groups, 
respectively (P < 0.01; OR: 2.85; CI 95%: 1.38 5.9). 
In  both  groups,  only  one  was  positive  for  anti 
Chlamydia  IgM  antibody.  The  anti  Chlamydia  IgG 
seropositivity rate was higher in patients older than 50 
years  old  than  those  younger  than  50  years  old  
(OR: 2.83; CI 95%: 1.31 1.14). 
  The  relation  between  anti  Chlamydia  IgG 
seropositivity and myocardial infarction and its related 
risk factors is presented in Table 2. 
 
Table 1. Demographic charactristics and risk factors in case and control groups 
Variable 
Case  Control 
P value 
Number (%)  Number (%) 
Sex 
Female  21 (23.9)  26 (53.1) 
0.001 
Male  67 (76.1)  23 (46.9) 
Age(y) 
≤ 50  27 (30.7)  16 (32.7) 
0.82 
> 50  61 (63.9)  33 (67.3) 
BMI(kg/m2) 
< 20  15 (17.1)  5 (10.2) 
0.14  20   25  42 (47.7)  32 (65.3) 
> 25  31 (35.2)  12 (24.5) 
Hypertention 
No  65 (73.9)  44 (89.8) 
0.03 
Yes  23 (26.1)  5 (10.2) 
Diabetes 
No  78 (88.6)  47 (95.9) 
0.15 
Yes  10 (11.4)  2 (4.1) 
Hyperlipidemi 
No  64 (72.7)  48 (98) 
<0.001 
Yes  24 (27.3)  1 (2) 
Smoking 
No  60 (68.2)  49 (100) 
<0.001 
Yes  28 (31.8)  0 (0) 
History of cold 
No  67 (76.1)  47 (95.9) 
0.003 
Yes  21 (23.9)  2 (4.1) 
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Table 2. The relation between positive anti chlamydia IgG and myocardial infarction and its related risk factors  
Risk factors  Number (%)  Chlamydia 
pneumoniae  OR (CI 95%)  P value 
Myocardial 
infarction 
No  49 (35.8)  23 (46.9)  1 
0.005 
Yes  88 (64.2)  63 (71.6)  2.85 (1.38   5.9) 
Age 
≤ 50  43 (31.4)  20 (46.5)  1 
0.01 
> 50  94 (68.6)  66 (70.2)  2.83 (1.31   1.14) 
BMI 
< 20  20 (14.6)  9 (45)  1 
0.03  20 - 25  74 (54)  47 (63.5)  3.57 (1.18   10.81) 
> 25  43 (31.4)  30 (69.8)  3.88 (1.2   12.56) 
Smoking 
No  109 (79.6)  63 (57.8)  1 
0.04 
Yes  28 (20.4)  23 (82.1)  3.68 (1.08  12.53) 
 
Discussion 
In  this  study,  we  investigated  the  relation  between 
both anti Chlamydia IgM and IgG seropositivity with 
myocardial  infarction  and  its  related  risk  factors. 
71.6%  and  1.1%  of  patients  with  acute  coronary 
syndrome had positive anti chlamydia IgG and IgM 
antibodies,  respectively.  The  anti  Chlamydia  IgG 
seropositivity  rate  was  significantly  higher  in  case 
group than control one and we concluded that there 
is  a  relation  between  anti  Chlamydia  IgG  antibody 
and acute myocardial infarction. 
  Chlamydia pneumoniae is responsible for most of 
Chlamydia infections in human and 90% of Chlamydia 
pneumoniae infections are mild or asymptomatic. Total 
anti  Chlamydia  seropositivity  rateis  estimated  to  be 
30% in middle aged adults, worldwide.  
  Reports  of  prevalence  of  antibodies  against  this 
infection  are  relatively  based  on  methods  used  for 
diagnosis  such  as  microimmunofluorescence, 
compliment  fixation,  and  enzyme  immunoassay. 
Determination of the cut off point and cross reaction 
with other species is also effective. IgM antibody is 
used  for  diagnosis  of  acute  infection.  IgG  class 
antibody titer is lasts for a long duration and reduces 
slowly  and  indicates  history  of  infection  with  an 
unknown  duration.  High  titers  of  IgG  are  of 
diagnostic value for chronic infection.8 
  In  recent  years  some  studies  have  investigated 
possible  role  of  Chlamydia  pneumoniae  in  coronary 
artery  diseases  and  controversial  results  has  been 
reported.  One  of  the  important  reasons  is  lacking  a 
microimmunofluorescence standard and variability of 
acceptable  cut off  titers  of  the  test.  Problems  in 
description of Chlamydia serologic tests and variability 
of methods of antibody detection has led to different 
cut off points in various studies, different methods of 
measurement and unique timing of sampling.9 
  Several  studies  have  supported  the  role  of 
Chlamydia  pneumoniae  in  the  initiation  and 
continuationof atherosclerosis.9 14  
  Constant  infection  of  Chlamydia  pneumoniae  in 
lungs  and  in  atherosclerotic  plaques  is  reported  in 
some  studies.15  Some  studies  did  not  support  the 
mentioned relation  between  Chlamydia  pneumoniae 
and  atherosclerosis  but  majority  of  studies  have 
reported  that  Chlamydia  infection  is  involved  in 
atherogenesis.9,10,16,17 
  Epidemiologic  studies  reveal  the  propagation  of 
Chlamydia infection around the world and majority of 
people are infected before age 20.18 
  In  a  study  conducted  on  relation  between 
Chlamydia  pneumoniae  and  metabolic  syndrome  in 
Taiwan  in  2009,  there  was  a  positive  association 
between older age, smoking and Chlamydia specific 
antibody that was consistent with our study.19 
  In our study 70% of subjects younger than 50 and 
77% of older than 55 years old subjects with acute 
myocardial  infarction  had  been  infected  with 
Chlamydia  pneumoniae.  Also  higher  rate  of  anti 
Chlamydia  IgG  seropositivity  in  male  patients  in 
comparison with females in this study could explain 
the  higher  incidence  of  atherosclerotic  diseases  in 
male patients.  
  The relation between Chlamydia seropositivity and 
hyperlipidemia,  diabetes  and  hypertension  was 
reported in some previous studies19, but there was no 
significant  relationship  between  mentioned  factors 
and anti Chlamydia seropositivity in current study. 
  Our  study  showed  a  significant  relationship 
between  obesity  and  Chlamydia  pneumonia  which 
was  consistent  with  some  studies  in  this  field.7,20 
Presence  of  atherosclerosis  in  patients  without  any 
typical  risk  factors  and  with  positive  Chlamydia 
pneumoniae infection can be related to these effects: 
direct  effects  of  Chlamydia  pneumoniae  on 
endothelium and their growth in endothelial cells and 
direct effects of the microorganism in preparation of 
macrophages for absorption of oxidize LDL which is 
the  first  step  of  atherogenesis  initiation.  So,  the 
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presence  of  Chlamydia  pneumoniae  along  with 
oxidative factors and oxidation can be possibly more 
important  than  hypercholesrolemia  in  the 
pathogenesis of atherosclerosis.5 
Conclusion 
In this study there was a significant relation between 
Chlamydia  pneumonia  seropositivity  and  acute 
myocardial  infarction  .Also,  our  study  showed  a 
significant  relationship  between  obesity,  older  age, 
smoking and Chlamydia pneumoniae seropositivity. 
  For  more  conclusive  findings  in  this  field  further 
investigation  with  larger  sample  size  is 
recommended.Also  considering  the  simplicity  of 
treatment, we suggest that all angina pectoris patients, 
obese persons, old patients, and smokers that are at risk 
for  acute  ischemic  accident  should  be  evaluated  and 
treated for this infection. 
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